top of page

AGENDA

Day 1: Friday 15 November 2024

​Opening Session
Chairperson: Dr. Mohamed Babiker

08:30 - 08:55        Neurogenetic disorders: current situation and future directions
                             Speaker: Dr. Mohamed Babiker
08:55 - 09:20        Genetic influence on brain development
                                 Speaker: Dr. Mohamed Almalik 
09:20 - 09:45        The spectrum of neurogenic disorders in the MENA region in the era of next generation sequencing
                             Speaker: Dr. Dina Saleh

Neurocutaneous Diseases
Chairperson: Dr. Ubaid Shah

09:45 - 10:10        Tuberous sclerosis updates 2024
                             Speaker: Dr. Pawan Kashyape
10:10 - 10:35        Advances in neurofibromatosis genetics: theory meets practice
                             Speaker: Dr. Hibba Bedri
10:35 - 11:00        Break

Movement Disorders
Chairperson: Dr. Biju Abdul Hameed 

11:00 - 11:25        Metabolic and genetic ataxias
                             Speaker: Prof. Brahim Tabarki Melaiki
11:25 - 11:50        The genetic landscape of hyperkinetic movement disorders
                             Speaker: Dr. Wejdan Hakami
11:50 - 12:15        Therapeutic advances in movement disorders: real life stories
                             Speaker: Dr. Mohamed Babiker

Genetic White Matter Diseases
Chairperson: Dr. Saleel Chandratre​

12:15 - 12:40        CNS hemophagocytic lymphohistiocytosis (HLH): the devil in disguise
                             Speaker: Prof. Hoda Tomoum
12:40 - 01:05        Genetic leukodystrophies: diagnostic clues and novel therapies
                             Speaker: Dr. Lamya Alsubaihi
01:05 - 02:30        Lunch Break & Prayer

Neurodegenerative Diseases
Chairperson: Prof. Pierre Krystkowiak

02:30 - 02:55        Inherited chorea
                                     Speaker: Prof. Pierre Krystkowiak
02:55 - 03:20        Inherited Parkinson disease
                             Speaker: Prof. Jean-Luc Houeto
03:20 - 03:45        The spinocerebellar ataxias: genotypes, phenotypes, and therapeutic opportunities
                             Speaker: Dr. Chloé Angelini
03:45 - 04:10        The type I interferonopathies: a decade on new frontiers
                             Speaker: Prof. Sunny Philip
04:10 - 04:35        Motor neuron disease: Can genes break the curse and provide hope for treatment
                             Speaker: Dr. Najwa Al Bustani
04:35 - 05:00        Break

Neurometabolic Diseases
Chairperson: Prof. Ayman El-Hattab

05:00 - 05:25        Neurometabolic disease: a practical guide to approach treatable causes
                             Speaker: Dr. Noura Al Dhaheri
05:25 - 05:50        Sulfite oxidase deficiency: diagnostic challenges
                             Speaker: Dr. Mohammed Mekki
05:50 - 06:15        Metabolic seizures
                             Speaker: Prof. Ayman El-Hattab

Day 2: Saturday 16 November 2024

Neurodevelopmental Disorders
Chairperson: Prof. Haitham Elbashir

08:30 - 08:55        The genetics of neurodevelopmental disorders
                             Speaker: Dr. Huda Sadek 
08:55 - 09:20        Spectrum of neurodevelopmental disorders in UAE
                             Speaker: Dr. Noura Al Dhaheri
09:20 - 09:45        Utility of whole exome sequencing in detecting neurodevelopmental disorders
                             Speaker: Dr. Sara Almheiri
09:45 - 10:10        Beyond conformity: childhood intellectual disabilities
                             Speaker: Dr. Alia Satti
10:10 - 10:35         Rett's syndrome: an overview and treatment perspectives
                             Speaker: Dr. Zeinab Alloub
10:35 - 11:00        Break

Neuromuscular Diseases 
Chairperson: Dr. Mehtab Iqbal

11:00 - 11:25        Genetic basis of neuromuscular disorders
                             Speaker: Dr. Omar Ismayl
11:25 - 11:50        Gene therapy in neuromuscular disorders: Experience from Qatar
                             Speaker: Prof. Tawfeg Ben-Omran
11:50 - 12:15        Duchenne therapies: approved and in the pipeline 
                             Speaker: Dr. Tarek El-Azzabi
12:15 - 12:40        Congenital myasthenia
                             Speaker: Dr. Fatmah Al-Zahmi
12:40 - 01:00        Spinal muscular atrophy gene therapy: long-term efficacy and safety
                             Speaker: Prof. Haitham Elbashir
01:00 - 02:00        Lunch

Genetic Epilepsies
Chairperson: Dr. Abdulla Alawadhi

02:00 - 02:25       Complexity in genetic epilepsies: a comprehensive approach
                            Speaker: Dr. Majid Aziz
02:25 - 02:50       Genetic epilepsies and precision medicine
                            Speaker: Dr. Arif Khan
02:50 - 03:15       Seizures in Angelman syndrome
                            Speaker: Dr. Samar Almuntaser
03:15 - 03:40       Genetics of the epilepsies: Perspectives from adult neurology practice
                            Speaker: Dr. Hamda Albastaki

Updates on Diagnostics
Chairperson: Dr. Syed Hosain

03:40 - 04:05       Closing the diagnostic gap for patients with rare neurogenetic diseases in the Middle East
                                         Speaker: Dr. Ahmad Abou Tayoun
04:05 - 04:30       Neuroimaging markers of neurogenetic disorders
                                         Speaker: Dr. Manigandan Thyagarajan
04:30 - 05:00       Break

Advancement in Therapy and Prevention
Chairperson: Dr. Vivek Mundada

05:00 - 05:25       Gene therapy and lessons learnt
                            Speaker: Dr. Vivek Mundada
05:25 - 05:50       Reducing the burden: Utility of preimplantation genetic testing in IVF
                                         Speaker: Dr. Elsamawal El Hakim
05:50 - 06:10       Abstract presentations
06:10 - 06:15       Closing remarks

bottom of page